New Blood Test Predicts Multiple Sclerosis Years Before Symptoms

Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titers

Multiple sclerosis (MS) is an immune-mediated demyelinating disease. Epstein-Barr virus (EBV) encodes for the EBNA-1381-452 region that induces autoreactive antibody responses, which are likely critically involved in MS pathogenesis. Here we investigate whether these EBNA-1381-452-specific antibodies can serve as a biomarker to identify at-risk individuals for MS. We quantify EBNA-1381-452-specific antibody titers from 324 relapsing-remitting MS…

New blood test predicts multiple sclerosis years before symptoms

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms.

New blood test predicts multiple sclerosis risk years before symptoms appear

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms. As a result, in the future, diagnostic and therapeutic measures could be taken early enough to delay or even prevent the onset of the disease. The research has just been published in Nature Communications.

This Virus, Exposed to 90% of People by Age 40, May Trigger Sclerosis Development

Long confined to the discreet role of virus responsible for mononucleosis, the Epstein-Barr virus returns today to the front of the scientific scene with a completely different face. Present in the organism of almost all adults, he has intrigued for years researchers who explore the origins of multiple sclerosis. A new study on a very large scale now brings solid evidence in favor of a direct link between this viral infection and the appearance …

GFAP protein levels may help predict MS disease severity...

Blood levels of a protein called GFAP, which reflects the activation and damage to support cells in the brain and spinal cord, may help predict disease severity and the response […] The post GFAP protein may help predict MS severity, response to treatment appeared first on Multiple Sclerosis News Today.